Research
We believe research that advances patient care and healing is an integral part of our mission. For over 25 years, we’ve been a leader in pharmacokinetic and clinical trials, investigating a wide range of subjects that directly impact the health of our patients.
Benefits for Patients
Participating in research and clinical trials often provides an opportunity for patients to receive free medical care and medication. To learn if you might qualify, please visit Current Research Studies
Benefits for Investigators and Sponsors
For research sponsors and investigators, we offer the opportunity to partner with an experienced team of researchers engaged in cutting-edge clinical practice and research in a wide variety of neurological disciplines.
Research Topics
Past and current research includes studies in the following areas.
• ALS (Lou Gehrig's Disease)
• Alzheimer's Disease
• Epilepsy
• Memory loss/dementia
• Migraine
• Multiple sclerosis
• Neuroimaging
• Neuro-oncology
• Neuropathic Pain
• Nuclear medicine
• Parkinson's Disease
• Psychiatry
• Stroke
Facilities
Located in suburban Buffalo, New York, our primary facility offers the following treatment and diagnostic capabilities.
• Urgent Care Center
• Analytic Laboratory
• PET Scanner
• MRI Scanner
• Polysomnograph Sleep Laboratory
• Carotid Doppler
• Specialty Clinics
• Headache Clinic
• Multiple Sclerosis Clinic
• ALS Clinic
• Infusion Centers
• Neuropsychometric Testing
• Regulatory Document Expert
|
|
Investigators
 Led by Research Director Fran Gengo, Pharm.D.
we
have produced over 60 papers and completed numerous clinical trials (phases II-IV). Onsite investigators and support staff include the following medical professionals.
Principal Investigators
Vernice Bates, M.D.
Horacio A. Capote, M.D.
Donna Czarnecki, PhD.
Marc Frost, M.D.
Tomas Holmlund, M.D.
Laszlo Mechtler, M.D.
Robert Miletich, M.D., PhD.
Malti Patel, M.D.
Support Staff
Mary Kay Betz, RPA-C
Malia DeAngelis, RPA-C
Namrata Kumar, RPA-C
Andrea Laudisio, RPA-C
Michelle Rainka, Pharm.D.
Carolyn Ross, RPA-C
Jason Santiago, RPA-C
Site Selection Advantages
As a private institution providing advanced diagnostics and treatment in a wide range of neurological subspecialties, we offer a compelling array of capabilities for research.
• Established clinical research infrastructure
• Experienced principal investigators who are board-certified and fellowship trained in their areas of expertise
• Ability to conduct phase II-IV clinical trials
In-house development of protocols for currently approved drugs
• Principal investigators with admitting privileges to several local hospitals to assist with serious adverse event follow-through
• Information technology capability for all aspects of clinical research
• New state-of-the-art research facility that includes an analytical laboratory, CRC, and infusion suites
• Rapid regulatory package and contract turnaround time for expedited start-up
• Ability to use centralized and localized IRBs as needed or required
• Flexible scheduled to accommodate monitors
• Large monitoring area with fax, copy, and internet capabilities
Sponsors and Partners
We have worked with the following sponsors and CROs.
• AstraZeneca
• Aventis (HMR)
• Bayer
• Boehringer Mannheim
• Bristol-Myers Squibb
• Covance
• DuPont
• Genentech
• Glaxo SmithKline Beecham
• Icon
• Merck
• NIH
• Novartis
• Pharmacia
• Pharmanet
• Pfizer
• Proctor & Gamble
• Quintiles, Inc.
• Sankyo
• Schering Plough Research Institute
• Searle
• Wyeth-Ayerst
Back to Top
|
|
